We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about the different phases of Chronic Myeloid Leukemia (CML), from the early chronic phase to the advanced blast phase. Understand the evolving symptoms, diagnostic methods, and the latest treatment options available, including Tyrosine Kinase Inhibitors (TKIs).

Chronic Myeloid Leukemia (CML) is a type of cancer that affects the blood-forming cells in your bone marrow. Specifically, it impacts the cells responsible for producing white blood cells, red blood cells, and platelets. In CML, a genetic mutation leads to the overproduction of abnormal white blood cells, known as blast cells. These abnormal cells multiply uncontrollably, crowding out healthy blood cells and impairing the bone marrow's ability to function correctly. CML typically progresses slowly, starting in a phase called the chronic phase, and can advance to more severe phases if left untreated.
CML is generally categorized into three distinct phases, each characterized by the percentage of blast cells in the blood or bone marrow and the presence of symptoms:
The chronic phase is the earliest and most treatable stage of CML. In this phase, blast cells typically constitute less than 10% of the cells in blood or bone marrow samples. Many individuals in the chronic phase may experience no noticeable symptoms. However, some may develop mild signs such as:
Without treatment, CML can progress to the accelerated phase. However, with timely and effective treatment, most people in the chronic phase can manage the disease and maintain a near-normal life expectancy.
CML enters the accelerated phase when the percentage of blast cells in the blood or bone marrow ranges between 10% and 19%. Symptoms experienced during the chronic phase may become more severe. Additionally, new symptoms might emerge, including:
Progression to the accelerated phase indicates that the leukemia is becoming more aggressive and requires prompt medical attention.
The blast phase, also known as blast crisis, is the most advanced and severe stage of CML. This phase is characterized by blast cells making up 20% or more of the blood or bone marrow samples. In this stage, blast cells have also begun to spread to other organs and tissues, such as the lymph nodes, liver, and spleen. Symptoms from the accelerated phase often become significantly more severe and life-threatening. Some critical symptoms of the blast phase include:
The blast phase is a critical medical emergency, and survival rates are significantly lower compared to the chronic phase. Without treatment, CML in the blast phase can be fatal within months.
As CML progresses through its phases, the symptoms typically become more pronounced and severe. It is crucial to be aware of these changes and report them to your doctor immediately. Key indicators that CML may be worsening include:
Diagnosing CML involves a combination of medical history, physical examination, and specific laboratory tests. The primary diagnostic tools include:
The advent of targeted therapies has revolutionized CML treatment, significantly improving outcomes and life expectancy. The primary treatment for CML is:
Currently, there are no known ways to prevent CML, as it is caused by a genetic mutation. However, maintaining a healthy lifestyle can support overall well-being and potentially help manage the disease and its treatment side effects:
It is essential to consult a doctor if you experience any persistent or concerning symptoms that could indicate CML or its progression. This includes:
Regular medical check-ups and prompt reporting of any new or worsening symptoms are crucial for early diagnosis and effective management of CML. Early detection and treatment in the chronic phase significantly improve the prognosis and quality of life for individuals with CML.
This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.
Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.
Track symptoms and duration.
Follow diagnosis and treatment from a licensed practitioner.
Review medication side effects with your doctor.
Seek urgent care for severe warning signs.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026